@article{63e71a1dec564634968c612a1b8e8c7e,
title = "The Heart Team for Coronary Revascularization Decisions: 2 Illustrative Cases",
abstract = "The 2021 ACC/AHA/SCAI coronary artery disease revascularization guideline highlights the importance of the multidisciplinary heart team in making patient-centered, evidence-based clinical decisions for patients considered for coronary revascularization. We present 2 cases highlighting aspects of heart team decision making for complex patients with coronary artery disease. (Level of Difficulty: Intermediate.)",
keywords = "clinical guideline, clinical practice guidelines, coronary artery bypass surgery, coronary artery disease, heart team, left main coronary artery disease, left ventricular dysfunction, multivessel coronary artery disease, patient-centered care, percutaneous coronary intervention",
author = "Metkus, {Thomas S.} and Beckie, {Theresa M.} and Cohen, {Mauricio G.} and Fremes, {Stephen E.} and Roxana Mehran and Sellke, {Frank W.} and Lawton, {Jennifer S.} and {Tamis Holland}, {Jacqueline E.}",
note = "Funding Information: Dr Metkus has reported salary support from the National Institutes of Health (NIH)–funded Institutional Career Development Core at Johns Hopkins (project No. 5KL2TR003099-02); has reported consulting unrelated to this subject matter for TelaDoc/BestDoctors Inc; has developed of educational materials for Oakstone/EBIX; and has received royalties for a textbook publication for McGraw-Hill publishing unrelated to this subject matter. Dr Cohen has reported consulting for Abiomed, Medtronic, Terumo Medical, and Merit Medical. Dr Fremes has reported being nominated principal investigator of the Canadian Institutes of Health Research (CIHR)–funded ROMA trial; co-investigator of the NIH-funded ROMA:QofL and ROMA:Cog trials; is co-investigator of the CIHR-funded VISION ECG substudy and the DEPOSITION trial; has reported serving on the data safety monitoring board of Polypid; and has reported being a local principal investigator of studies funded by Medtronic and Boston Scientific. Dr Mehran has reported institutional research grants from Abbott, Abiomed, Applied Therapeutics, Arena, AstraZeneca, Bayer, Biosensors, Boston Scientific, CardiaWave, CellAegis, CERC, Chiesi, Concept Medical, CSL Behring, DSI, Insel Gruppe AG, Medtronic, OrbusNeich, Philips, Transverse Medical, and Zoll; has received personal fees from ACC, Boston Scientific, California Institute for Regenerative Medicine (CIRM), Cine-Med Research, Janssen, WebMD, and the Society for Cardiovascular Angiography and Interventions; has reported consulting fees paid to the institution from Abbott, Abiomed, AM-Pharma, Alleviant Medical, Bayer, CardiaWave, CeloNova, Chiesi, Concept Medical, CSL Behring, DSI, Duke University, Idorsia Pharmaceuticals, Medtronic, Novartis, Philips; has reported <1% equity in Applied Therapeutics, Elixir Medical, STEL, and CONTROLRAD (spouse); has reported memberships on the Scientific Advisory Board for the American Medical Association and Biosensors (spouse); and reported being on the Faculty of the Cardiovascular Research Foundation (CRF) (no fee). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
month = feb,
day = "2",
doi = "10.1016/j.jaccas.2021.12.005",
language = "English (US)",
volume = "4",
pages = "115--120",
journal = "JACC: Case Reports",
issn = "2666-0849",
publisher = "Elsevier Inc.",
number = "3",
}